Protagonist Therapeutics (PTGX) EPS (Basic) (2015 - 2026)
Protagonist Therapeutics (PTGX) reported EPS (Basic) of $0.06 for Q1 2026, up 131.4% on a YoY basis from $0.03 in Q1 2025, and up 108.32% sequentially from -$0.7 in Q4 2025.
Protagonist Therapeutics (PTGX) EPS (Basic) (2015 - 2026) Analysis & Trends
Protagonist Therapeutics (PTGX) has 12 years of EPS (Basic) data on file, last reported at $0.06 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 131.4% year-over-year to $0.06; the trailing twelve-month figure through Mar 2026 stood at -$1.76 (down 297.65% YoY), and the FY2025 full-year result was -$2.05, down 145.81% from the prior year.
- EPS (Basic) improved to $0.06 in Q1 2026, from -$0.7 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $3.41 in Q1 2024 to a low of -$1.37 in Q1 2022.
- A 5-year average of -$0.13 and a median of -$0.58 in 2023 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) plunged 153.04% in 2022 and surged 610.99% in 2024, its largest moves.
- Tracing PTGX's EPS (Basic) over 5 years: stood at -$0.71 in 2022, then soared by 208.59% to $0.77 in 2023, then jumped by 176.32% to $2.14 in 2024, then plunged by 132.66% to -$0.7 in 2025, then surged by 108.32% to $0.06 in 2026.
- Business Quant data shows PTGX's EPS (Basic) at $0.06 in Q1 2026, -$0.7 in Q4 2025, and -$0.62 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Protagonist Therapeutics | 8.88 Bn | 8.88 Bn | - | 0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.06 |
| Dec 31, 2025 | -0.70 |
| Sep 30, 2025 | -0.62 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -0.19 |
| Dec 31, 2024 | 2.14 |
| Sep 30, 2024 | -0.54 |
| Jun 30, 2024 | -0.50 |
| Mar 31, 2024 | 3.41 |
| Dec 31, 2023 | 0.77 |
| Sep 30, 2023 | -0.58 |
| Jun 30, 2023 | -0.68 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -0.71 |
| Sep 30, 2022 | -0.68 |
| Jun 30, 2022 | -0.87 |
| Mar 31, 2022 | -1.37 |
| Dec 31, 2021 | -0.80 |
| Sep 30, 2021 | -0.70 |
| Jun 30, 2021 | -0.69 |